273 related articles for article (PubMed ID: 26397178)
1. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
[TBL] [Abstract][Full Text] [Related]
2. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
3. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Xie L; Frech-Tamas F; Marrett E; Baser O
Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Observational Real-Word Analysis of the Adherence, Healthcare Resource Consumption and Costs in Patients Treated with Bisoprolol/Perindopril as Single-Pill or Free Combination.
Masi S; Kobalava Z; Veronesi C; Giacomini E; Degli Esposti L; Tsioufis K
Adv Ther; 2024 Jan; 41(1):182-197. PubMed ID: 37864626
[TBL] [Abstract][Full Text] [Related]
5. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS
Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
[TBL] [Abstract][Full Text] [Related]
6. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and/or Dyslipidemia: Results of a Meta-Analysis.
Weisser B; Predel HG; Gillessen A; Hacke C; Vor dem Esche J; Rippin G; Noetel A; Randerath O
High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):157-164. PubMed ID: 32219670
[TBL] [Abstract][Full Text] [Related]
7. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
[TBL] [Abstract][Full Text] [Related]
8. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of single-pill combination of indapamide and amlodipine in the treatment of arterial hypertension in the Polish setting.
Kawalec P; Holko P; Stawowczyk E; Borowiec Ł; Filipiak KJ
Kardiol Pol; 2015; 73(9):768-80. PubMed ID: 25987296
[TBL] [Abstract][Full Text] [Related]
10. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
Malesker MA; Hilleman DE
Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
[TBL] [Abstract][Full Text] [Related]
11. A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
Snyman JR; Bortolotto LA; Degli Esposti L; Jayagopal PB; Konradi AO; Perrone V; Borghi C
J Hypertens; 2024 Jan; 42(1):136-142. PubMed ID: 37728093
[TBL] [Abstract][Full Text] [Related]
12. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations.
Brixner DI; Jackson KC; Sheng X; Nelson RE; Keskinaslan A
Curr Med Res Opin; 2008 Sep; 24(9):2597-607. PubMed ID: 18812017
[TBL] [Abstract][Full Text] [Related]
13. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
14. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
[TBL] [Abstract][Full Text] [Related]
15. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
Sicras Mainar A; Galera Llorca J; Muñoz Ortí G; Navarro Artieda R
Med Clin (Barc); 2011 Feb; 136(5):183-91. PubMed ID: 21106209
[TBL] [Abstract][Full Text] [Related]
16. [Medication adherence with the fixed combination of ramipril and amlodipine].
Simonyi G; Ferenci T
Orv Hetil; 2014 Nov; 155(47):1882-8. PubMed ID: 25403283
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
19. China STudy of valsartan/amlodipine fixed-dose combination-bAsed long-Term blood pressUre management in HypertenSive patients: a one-year registry (China STATUS III).
Huo Y; Gu Y; Ma G; Guo J; Xiong L; Luo Z; Xie J; Li W; Zhao J; Yan X; Liu W; Xu Y; Bao X; Zhao L; Yang M; Wang B; Iii Study Group TCS
Curr Med Res Opin; 2019 Aug; 35(8):1441-1449. PubMed ID: 30880492
[No Abstract] [Full Text] [Related]
20. Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
Schmieder RE; Wassmann S; Predel HG; Weisser B; Blettenberg J; Gillessen A; Randerath O; Mevius A; Wilke T; Böhm M
Hypertension; 2023 May; 80(5):1127-1135. PubMed ID: 36987918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
